Ankyra Therapeutics

Series-B
ankyratx.com Biotech & Healthcare Boston, United States
Total Funding Undisclosed
Latest Round Undisclosed Series-B
Last Announced Oct 2, 2024
Investors 7 Backers
Decision Makers 6 Available

About Ankyra Therapeutics

Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Boston, United States
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website ankyratx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @ankyratx (40 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

Investors & Backers

7
Borealis Ventures
Fidelity
GV
Mithril Capital
Polaris
Sands Capital Ventures
Spring Mountain Capital

Funding History

1 Round
Series-B equity · Oct 2, 2024

Founders & Leadership

7

Darrell Irvine

Founder

Work email & phone locked Unlock →

Howard L. Kaufman

President and Chief Executive Officer

Work email & phone locked Unlock →

K. Dane Wittrup

Founder

Work email & phone locked Unlock →

Michael Schmidt

Chief Scientific Officer

Work email & phone locked Unlock →

Robert V. Tighe

Chief Scientific Officer

Work email & phone locked Unlock →

Sailaja Battula

Chief Scientific Officer

Work email & phone locked Unlock →

Stephen Gorgol

Chief Financial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts